4098.0: Tuesday, November 14, 2000: 12:30 PM-2:00 PM

Monitoring HIV and Injection Drug Users Issues II

See individual abstracts for presenting author's disclosure statement.
Learning Objectives: Refer to the individual abstracts for learning objectives
Board 1Developing Prevention Interventions for HIV+ Injection Drug Users (IDUs) That Incorporate Peer Support and Advocacy
Kelly Ray Knight, MEd, Starley B. Shade, MPH, Carol S. Dawson-Rose, PhD, Cynthia A. Gomez, PhD, SUDIS Team
Board 2Disparity in receipt of preventive health care services by chronic drug users in Miami, Florida
Clyde B. McCoy, PhD, Lisa R. Metsch, PhD, Dale D. Chitwood, PhD, Margaret Pereyra, MPH
Board 3Drug-scene roles and HIV risk among Puerto Rican injection drug users (IDUs) in East Harlem, New York City and Bayamón, Puerto Rico
Samuel R. Friedman, PhD, Sung-Yeon Kang, PhD, Sherry Deren, PhD, Rafaela Robles, PhD, Rafaela Robles, PhD, Hector M. Colón, Jonny F. Andia
Board 4Effect of knowing HIV serostatus on risk behaviors among injection drug users in Chicago
Dezheng Huo, MD, Lawrence J Ouellet, PhD, Susan L Bailey, PhD, Lorna E Thorpe, PhD
Board 5Experiences with violence: Comparisons of Puerto Rican drug users in New York and Puerto Rico
H. Ann Finlinson, PhD, Rafaela R. Robles, EdD, Denise Oliver-Velez, PhD, Sherry Deren, PhD, Hector M. Colon, PhDc, John G. H. Cant, PhD, Jonny Andia, PhDc, Jonny Andia, PhDc, Mayra Soto-Lopez
Board 6Hepatitis C and alcohol preference among injection drug users in Anchorage, Alaska
Rebecca S. Wells, SM, Dennis G. Fisher, PhD, Andrea M. Fenaughty, PhD, Henry H Cagle, BS
Board 7Moving beyond street-based outreach: Three service delivery models for needle exchange programs
Samuel A. MacMaster, PhD, candidate, Kenneth A. Vail, MA, MPH, Joyce Perkins, MA, James Alan Neff, PhD, MPH
Board 8Predicting HIV risk behaviors: The utility of the PRECEDE model
Sherry Deren, PhD, Bruce Rapkin, PhD, Sung-Yeon Kang, PhD, Rafaela Robles, PhD, Jonny Andía, MS, Hector Colón, MA
Board 9Risk factors for abscesses in injectors of “black tar” heroin: A cross-methodological approach
Dan Ciccarone, MD, MPH, Philippe Bourgois, PhD, Edward L. Murphy, MD, MPH, Alexander H Kral, Karen H Seal, MD, MPH, Jeffry D. Moore, Brian R. Edlin, MD
Board 10Trends in Diagnoses of HIV Infections Among Injection Drug Users Aged 13-25 as a Proxy Indicator of HIV Incidence in this Age Group, 25 HIV Reporting States, United States, 1994 – 1998
Tadesse Wuhib, MD, MPH, Tadesse Wuhib, MD, MPH, Jianmin Li, DPE, Pascale Wortley, MD, MPH
Sponsor:Alcohol, Tobacco, and Other Drugs
Cosponsors:Epidemiology; HIV/AIDS SPIG; Social Work

The 128th Annual Meeting of APHA